Imugene (ASX:IMU) appointed John Byon as chief medical officer (CMO), effective immediately, according to a Friday filing with the Australian bourse.
Byon succeeds outgoing CMO Paul Woodard, the filing said.
Shares of the company fell 6% and earlier hit an all-time low.